Great to see you back again Bigpharma. I think it was you that mentioned the "sink effect" of trying to use pyc cell penetrating tech in humans rather than mice. I thought that was why targeting the eye was such a good move. Surely that limits the sink effect to a huge degree if only injecting onto the eye? Obviously still needs to be proven in real human trials but they seem to have shown good progress to date in petri dishes with human derived samples?
Ann: PYC Expands US Executive Leadership Team, page-12
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.8¢ | $519.2K | 5.169M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 182466 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 101115 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |